SCHEMBL601358

SCHEMBL601358

CC1[CH]CCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21827253 1.00
SCHEMBL21827191 1.00
SCHEMBL14635960 0.82
SCHEMBL20425156 0.82
SCHEMBL16877073 0.77
SCHEMBL2012570 0.72
SCHEMBL23072739 0.71
SCHEMBL10296437 0.71
SCHEMBL22362306 0.62
SCHEMBL2040256 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4284797-A1 PYRAZOLEAMIDE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2023-12-06 EP claimed
US-20230382911-A1 PYRAZOLEAMIDE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2023-11-30 US claimed
US-11612606-B2 8-aminoisoquinoline compounds and uses thereof GENENTECH, INC. (US) 2023-03-28 US claimed
CN-107698541-A The preparation method of 3 tetrahydrofurfuryl carbinols 陕西启源科技发展有限责任公司 2018-02-16 CN claimed
CN-107382916-A The high purity synthetic process of 3 tetrahydrofurfuryl carbinols 成都化润药业有限公司 2017-11-24 CN claimed
CN-107226798-A The new technology of 3 tetrahydrofurfuryl carbinols of synthesis is reacted by Prins 成都化润药业有限公司 2017-10-03 CN claimed
CN-107141273-A Using the new technology of the methanol of one pot process tetrahydrofuran 3 成都化润药业有限公司 2017-09-08 CN claimed
EP-2603218-B1 QUINOLYL AMINES AS KINASE INHIBITORS GLAXOSMITHKLINE IP DEV LTD (GB) 2016-03-02 EP claimed
EP-2566477-B1 AMINO-QUINOLINES AS KINASE INHIBITORS GLAXOSMITHKLINE IP DEV LTD (GB) 2015-09-02 EP claimed
EP-2603218-A1 QUINOLYL AMINES AS KINASE INHIBITORS GlaxoSmithKline Intellectual Property Development Limited (GB) 2013-06-19 EP claimed
EP-1506185-A1 NOVEL COMPOUNDS AND THEIR USE Biovitrum AB (SE) 2005-02-16 EP claimed
US-20030232814-A1 Novel compounds and their use BIOVITRUM AB (PUBL) (SE) 2003-12-18 US claimed
WO-2003097636-A1 NOVEL COMPOUNDS AND THEIR USE BIOVITRUM AB (SE) 2003-11-27 WO claimed
EP-0984778-B1 NEUROPEPTIDE-Y LIGANDS AGOURON PHARMA (US) 2002-06-12 EP claimed
EP-0984778-A4 NEUROPEPTIDE-Y LIGANDS ALANEX CORP (US) 2000-06-07 EP claimed
EP-0984778-A1 NEUROPEPTIDE-Y LIGANDS Alanex Corporation (US) 2000-03-15 EP claimed
WO-1998007420-A1 NEUROPEPTIDE-Y LIGANDS AGOURON ACQUISITION CORP. (US) 1998-02-26 WO claimed
US-5436262-A Pharmacologically active derivatives of 2-(benzimidazol-2-yl)-1,3-diaminopropane DOMPE FARMACEUTICI SPA (IT) 1995-07-25 US claimed
EP-0630889-A1 Pharmacologically active derivatives of 2-(benzimidazol-2-yl)-1,3-diaminopropane DOMPE' FARMACEUTICI S.p.A. (IT) 1994-12-28 EP claimed
WO-1993012113-A1 3-SUBSTITUTED IMIDAZO (1,5-a) AND IMIDAZO (1,5-a)-TRIAZOLO (1,5-c) QUINOXALINES AND QUINAZOLINES WITH CNS ACTIVITY THE UPJOHN COMPANY (US) 1993-06-24 WO claimed